EXAMINE Investigators Close All authors

Publications
Contact
View All

selected publications

Journal Article
- Alogliptin in patients with type 2 diabetes receiving metformin and sulfonylurea therapies in the EXAMINE Trial. American Journal of Medicine. 2018
- Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: the EXAMINE trial. Diabetes, Obesity & Metabolism. 2017
- Angiotensin-converting enzyme inhibitor use and major cardiovascular outcomes in type 2 diabetes mellitus treated with the dipeptidyl peptidase 4 inhibitor alogliptin. Hypertension (Dallas, Tex.. 2016
- Cardiovascular mortality in patients with type 2 diabetes and recent acute coronary syndromes from the EXAMINE Trial. Diabetes care. 2016
- Alogliptin after acute coronary syndrome in patients with type 2 diabetes. New England Journal of Medicine. 2013
Abstract
- Alogliptin in triple therapy with metformin and sulfonylureas provides significant reductions in HbA1c and is well tolerated: an analysis from the EXAMINE Trial [abstract]. Diabetes. 2016